Order Velaglucerase Alfa in India 
                     Order Velaglucerase
 Alfa in India 
Pricing & Supplier Info
Velaglucerase alfa is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher 
disease. Gaucher disease is an autosomal recessive disorder where GBA gene mutation results in deficiency of beta-
glucocerebrosidase. This lysosomal enzyme catalyzes conversion of the sphingolipid glucocerebroside into glucose 
and ceramide. However, in deficiency of this enzyme glucocerebroside can accumulate in the lysosomal compartment 
of macrophages, giving rise to foam cells or “Gaucher cells”. Velaglucerase alfa catalyzes hydrolysis of this 
glucocerebroside, reducing its amount.
In clinical trials, this product reduced spleen and liver size, and improved anemia and thrombocytopenia. The most 
common adverse reactions include hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back 
pain, joint pain, prolonged activated PTT, fatigue/asthenia, and pyrexia. Available data does not establish or exclude 
the absence of a velaglucerase alfa associated risk during pregnancy or any major birth defects, miscarriage, or any 
other adverse maternal or fetal outcomes. Sufficient data is not available to determine any effects on the breastfed 
infant or on milk production. Endogenous beta-glucocerebrosidase is present in human milk. The benefits of 
breastfeeding should be taken into consideration along with the mother’s clinical need for the medicine and any 
potential adverse effects on the breastfed child or from the underlying maternal condition.
Safety and effectiveness have been established for enzyme replacement therapy (ERT) in patients in the range of 4-17 years of age 
with type 1 Gaucher disease. The safety and efficacy profiles were similar between pediatric and adult patients. However, the 
efficacy and safety of the product has not been established in pediatric patients younger than 4 years of age.
Reported clinical experience has not identified differences in responses between geriatric and younger patients. Dose selection for 
an elderly patient should be approached cautiously, considering potential comorbid conditions.
Pricing and availability 
Velaglucerase alfa is not currently registered in India and is therefore not available through regular pharmacies or standard 
distribution channels.
As this is a prescription-only medication, a price quotation for obtaining information on price of velaglucerase alfa in India, is 
shared only after reviewing valid medical documents and a doctor’s prescription. For the most up-to-date pricing and supply 
details, patients may contact our support team to access and buy velaglucerase alfa in India.
The price of velaglucerase alfa in India may differ based on factors such as market demand, supplier access, import regulations, and 
availability from international manufacturers. The total cost may also depend on shipping charges, origin country, documentation 
fees, and currency exchange rates.
Pricing may be affected by local taxes (GST) and any revisions in company or distributor pricing policies.
We assist patients in India with the safe and lawful access to velaglucerase alfa through the Named Patient Supply 
(NPS) program, ensuring compliance with all import regulations. Our services include document verification, 
import coordination, and doorstep delivery of the medicine.
Patient Access
Since velaglucerase alfa is not approved for commercial sale in India, it can be obtained 
only through the Named Patient Import Program (NPIP). We help patients obtain 
unregistered medicines like velaglucerase alfa under the NPS route, maintaining full 
adherence to applicable legal and regulatory standards.
Velaglucerase alfa is available as 400 units/vial, for injection as a sterile, preservative free, 
white to off-white lyophilized powder requiring reconstitution and dilution before using. It is 
supplied in individually packaged single-dose glass vials.
Pricing may be affected by local taxes (GST) and any revisions in company or distributor pricing policies.
We assist patients in India with the safe and lawful access to velaglucerase alfa through the Named Patient Supply 
(NPS) program, ensuring compliance with all import regulations. Our services include document verification, 
import coordination, and doorstep delivery of the medicine.
Patient Access
Since velaglucerase alfa is not approved for commercial sale in India, it can be obtained 
only through the Named Patient Import Program (NPIP). We help patients obtain 
unregistered medicines like velaglucerase alfa under the NPS route, maintaining full 
adherence to applicable legal and regulatory standards.
Velaglucerase alfa is available as 400 units/vial, for injection as a sterile, preservative free, 
white to off-white lyophilized powder requiring reconstitution and dilution before using. It is 
supplied in individually packaged single-dose glass vials.
Import Procedure
• Medicine Request Submission
Patients or caregivers can begin by submitting a request, along with their doctor’s prescription and treatment 
information.
• Filing Form 12A
A completed Form 12A and a valid prescription from a Registered Medical Practitioner (RMP) must be 
submitted.
• Verification Process
All documents are carefully reviewed to confirm the patient’s eligibility to import the medicine for personal 
medical use.
• Regulatory Approval
Once approval is received from the Drugs Controller General (India), the import procedure is initiated in 
accordance with the approved prescription.
• Medicine Procurement
Our procurement specialists connect with licensed international suppliers to source the medicine at the best 
possible rate while ensuring authenticity and quality.
• Product Delivery
Following approval and shipment, logistics are handled to ensure timely, safe, and compliant delivery of the 
medicine to the patient’s address in India.
Documents required
To import velaglucerase alfa into India, patients must provide the following:
• A valid prescription indicating the medicine name, dosage, duration, and diagnosis.
• Recent medical history and diagnostic reports (preferably from the last three months).
• Government-issued ID proof and proof of residence.
• Import permit (if required).
Orders are confirmed only after the submission and verification of all necessary documents. Once the import 
authorization is granted, shipment velaglucerase alfa is arranged by a licensed global supplier—typically from the 
USA, Canada, Europe, or Australia.
This process ensures that patients in India can legally and securely access velaglucerase alfa. We coordinate with 
reliable international sources, maintain pricing transparency, and ensure all deliveries are pharmacist-verified and 
fully compliant with import regulations.
If you are a patient seeking detailed information, expert guidance, or pricing for specific medications, you can 
contact 247qualitymeds.com. The platform provides reliable support, accurate product details, and assistance 
throughout the inquiry and ordering process.
For product related information please visit: 247Qualitymeds